Sports rehabilitation has seen steady technological progress, but its clinical effectiveness remains constrained by persistent challenges, including ...

A locally owned physical therapy and sports medicine clinic in Gettysburg is leaning on long one-on-one sessions, quick ...

WebPT, the leading rehab therapy platform designed to help practices power efficiency, grow revenue, and manage every aspect of their practice, today announces the winners of its 2025 Ascend Awards.

Martin Army Community Hospital has launched a new virtual physical therapy pilot aimed at strengthening Soldier readiness by ...

A physical therapist is sentenced to probation as the fifth of 19 defendants to be sentenced in Hertel & Brown health care fraud. The defendant's remorse and the support of a patient's family helped ...

uniQure N.V. (QURE) stock fell following feedback from the U.S. FDA during a recent pre-Biologics License Application (BLA) meeting about AMT-130, a gene therapy being investigated for Huntington’s ...

On Tuesday, the U.S. Food and Drug Administration (FDA) accepted Rocket Pharmaceuticals, Inc.’s (NASDAQ:RCKT) resubmission of the Biologics License Application (BLA) for Kresladi (marnetegragene ...

Oct 3 (Reuters) - Rocket Pharmaceuticals (RCKT.O), opens new tab said on Friday it has withdrawn its application for U.S. approval of its experimental gene therapy for a rare inherited blood disorder.

Please provide your email address to receive an email when new articles are posted on . This is the first biologics license application submitted for a gene-agnostic retinal disease gene therapy.

Sangamo Therapeutics’ investigational gene therapy appears to improve kidney function at 52 weeks for patients with a rare genetic disorder. The biotech plans to use the data for an FDA submission ...